Literature DB >> 152519

Altered activity of hepatic mixed-function mono-oxygenase enzymes in streptozotocin-induced diabetic rats.

L A Reinke, S J Stohs, H Rosenberg.   

Abstract

1. In streptozotocin-induced diabetic male rats, hepatic microsomal aminopyrine N-demethylase activity was depressed, whereas aniline hydroxylase activity and cytochrome P-450 content were increased over control values. 2. In diabetic female rats, hepatic microsomal aminopyrine N-demethylase activity, aniline hydroxylase activity, biphenyl 4-hydroxylase activity, and cytochrome P-450 content were increased over control values. 3. Insulin treatment of diabetic male and female rats antagonized all physical and biochemical abnormalities of the diabetic state; 4. Methyl analogues of streptozotocin did not produce a diabetic state when injected into female rats, and resulted in no changes in aminopyrine N-demethylase activity, aniline hydroxylase activity, or cytochrome P-450 content. 5. Insulin treatment of non-diabetic female rats resulted in slight decreases in aminopyrine N-demethylase and aniline hydroxylase activities, but no changes in cytochrome P-450 content. These observations suggest that insulin primarily influences drug metabolism of diabetic animals through correction of the insulin-deficient diabetic state.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 152519     DOI: 10.3109/00498257809069573

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  11 in total

1.  Diabetes alters drug metabolism--in vivo studies in a streptozotozin-diabetic rat model.

Authors:  T Zysset; L Sommer
Journal:  Experientia       Date:  1986-05-15

2.  Immunoquantitation of some cytochrome P-450 isozymes in liver microsomes from streptozotocin-diabetic rats.

Authors:  E Rouer; P Beaune; J P Leroux
Journal:  Experientia       Date:  1986-10-15

3.  Hepatic estrogen and androgen receptors and binding proteins in streptozotocin-diabetic male Wistar rats.

Authors:  D R Smith; M R Rodway; W A Haniak; G D Bellward
Journal:  Diabetologia       Date:  1987-12       Impact factor: 10.122

4.  Influence of streptozotocin-diabetes on the pharmacokinetics, placental transfer and tissue localization of dexamethasone in rats.

Authors:  S Mulay; D R Varma
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

5.  Induction and suppression of renal and hepatic cytochrome P450-dependent monooxygenases by acute and chronic streptozotocin diabetes in hamsters.

Authors:  T L Chen; S H Chen; T Y Tai; C C Chao; S S Park; F P Guengerich; T H Ueng
Journal:  Arch Toxicol       Date:  1996       Impact factor: 5.153

6.  Pharmacokinetics of caffeine in patients with decompensated type I and type II diabetes mellitus.

Authors:  T Zysset; H Wietholtz
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

7.  Telithromycin pharmacokinetics in rat model of diabetes mellitus induced by alloxan or streptozotocin.

Authors:  Joo H Lee; Myung G Lee
Journal:  Pharm Res       Date:  2008-05-14       Impact factor: 4.200

8.  Differential effect of type I and type II diabetes on antipyrine disposition in man.

Authors:  T Zysset; H Wietholtz
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

9.  Metabolic activation of chemical carcinogens by hepatic preparations from streptozotocin-treated rats.

Authors:  P R Flatt; S L Bass; A D Ayrton; J Trinick; C Ioannides
Journal:  Diabetologia       Date:  1989-02       Impact factor: 10.122

10.  Studies on the mechanism of alloxan-diabetes potentiation of carbon tetrachloride-induced liver necrosis.

Authors:  M C Villarruel; G Fernández; E C de Ferreyra; O M de Fenos; J A Castro
Journal:  Br J Exp Pathol       Date:  1982-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.